BIO.ai Roadmap

Scientific Autonomous Agent Staking as a Service (SAASaaS)

Executive Summary

This roadmap outlines a multi-agent, AI-driven pipeline for decentralized research—transforming Biotechnology Decentralised Autonomous Organisations (BioDAOs) into efficient, collaborative hubs of scientific innovation. 

To date, BioDAOs have faced challenges scaling their current model of community-led research. This model relies on members to find and suggest projects for funding, creating a global pipeline of IP-NFTs. 

The current approach has not scaled because it's slow and challenging to work with universities, identify quality science, and secure funding. Additionally, DAOs aren't effectively utilizing their communities, as members are limited to voting on core group proposals without significant governance or oversight.

This roadmap attempts to address these issues, reforming the operations of BioDAOs to be more AI centric, conferring numerous benefits:

Figure 1: Benefits of BioDAOs in AI-Driven Research

It starts through gathering and curating knowledge via multi-agent systems into a robust data backbone as a decentralised knowledge graph; this information is used to propose and refine novel hypotheses through specialised agents.

Once a community-governed DAO (e.g., via a bonding curve, prediction markets and on-chain voting) selects the most promising ideas, they are converted into actionable R&D plans, streamlining laboratory workflows and automatically generated legal agreements. The final stage safeguards and monetizes each discovery through advanced licensing frameworks or IP-NFTs using the Molecule Protocol.

Figure 2: Transforming BioDAOs into Scientific Hubs

By leveraging AI and autonomous agents within a decentralized science (DeSci) framework, this roadmap aims to supercharge serendipitous discoveries, foster interdisciplinary collaborations, and drive a novelty explosion in biomedical research and the creation of protectable intellectual property.

Introduction

This roadmap outlines a multi-agent, AI-driven pipeline designed to transform BioDAOs into efficient and collaborative hubs of scientific innovation. This initiative is a collaborative effort drawing expertise from industry leaders in the DeSci*AI intersection, leveraging the strengths of numerous organizations to drive advancements in DeSci.

To date, BioDAOs have encountered challenges in scaling their community-led research model, which predominately relies on members to propose projects for funding, and to a lesser extent organically attracting scientists who understand crypto. This results in a slow process for identifying quality science, working with universities, and securing funding.

This roadmap introduces a solution to these challenges by detailing the development and implementation of Scientific Autonomous Agent Staking as a Service (SAASaaS). This will be a driver for ubiquitous citizen science.

The aim is to develop an all-in-one application designed to streamline entry into the world of autonomous scientific research, and earn rewards for contributing resources to the network. Anyone should be able to participate in and own a share of the output of SAASaaS without special skills or advanced hardware, making it the accessible and transparent platform to launch groundbreaking experiments.

The first iteration of these agents will be a "contributor agent" helping to create the "decentralised knowledge graph". Over time, other agents in the roadmap will be added, creating a fully integrated pipeline of innovation.

Decentralized Knowledge Graphs (DKGs) are a core component of BIO.ai because they address the fragmentation and inaccessibility of scientific data that hinder breakthroughs. DKGs unify scattered research findings into a single AI-ready knowledge base, ensuring that critical insights aren't overlooked. By verifying data authenticity via blockchain-based proofs and automating relational linking, DKGs enable AI agents to continuously scan findings and surface hidden connections, reducing duplication of effort and accelerating discovery.

This focus on DKGs aims to return to the original vision of the semantic web, providing a modern, decentralized twist that bridges neural and symbolic AI to ensure verifiable, interpretable, and trustworthy biomedical outcomes

Multi-Agent Systems

The following Agent for Specific Workflows align with the five overarching categories:

• Contributor Agents responsible for gathering and organizing data
• Consumer Agents tasked with generating and choosing hypotheses
• Designer Agents who formulate experimental plans
• Contract Agents managing real-world R&D execution
• IP Agents overseeing IP, patents, and data rights

Figure 3: Data Driven Discovery Coordinated by Autonomous Agents

The Contributor Agents are foundational. They ensure that the system starts with high‐fidelity, curated data. Any downstream hypothesis‐generation or R&D workflow will rely on these clean, well‐organized knowledge assets.

Once the data is structured by Contributor Agents, the Consumer Agent leverages it to produce actionable ideas. These agents ensure the system continuously surfaces novel hypotheses worth testing—critical for fueling the R&D pipeline.

The Designer Agent bridges the gap between “abstract hypothesis” and “practical R&D plan.” By automating (or semi‐automating) experimental design, it drastically reduces the time and cost of moving a promising idea into real‐world testing.

Even the most elegant experimental design needs real‐world execution. The Contract Agent ensures that the legal, logistical, and manufacturing processes are streamlined and on‐chain (where feasible), cutting administrative overhead and ensuring traceable, verifiable workflows.

The final agent closes the loop from early hypothesis to validated IP. By bundling data, experiments, and IP rights into an IP‐NFT, it creates a transparent and traceable asset that can be licensed, traded, or leveraged for funding.

Figure 4: The Five Agent Workflow to Creating Hypotheses -> IP

See here for full picture: https://miro.com/app/board/uXjVLqIwafI=/ 

Knowledge Graph Integration

The BIO.ai ecosystem leverages a DKG for several critical reasons, all aimed at transforming BioDAOs into engines of accelerated and impactful scientific discovery. This approach addresses the limitations of today's scientific knowledge management, where information is fragmented across disconnected databases, journals, and repositories.

By creating a unified, accessible, and verifiable knowledge base, BIO.ai aims to "supercharge serendipitous discoveries" and foster a "novelty explosion" in biomedical research.

Figure 5: DKG’s Role in Research Transformation

Here's why we're leveraging a DKG:

• Overcoming Data Silos and Fragmentation: DKG breaks down barriers, creating a shared pool of knowledge accessible to researchers worldwide.
• Ensuring Data Provenance and Trust: DKG ensures that every piece of information is traceable, verifiable, and securely owned, establishing provenance crucial for validating results.
• Enhancing AI Model Performance: Pairing LLMs with DKGs grounds AI in verifiable data, dramatically reducing misinformation/hallucination.
• Facilitating "Knowledge Expeditions": DKG, combined with AI agents, facilitates rapid cross-disciplinary exploration, uncovering fresh challenges and ideas.
• Automating Knowledge Mining: BioGraph handles the heavy lifting of tagging and organizing data using AI, freeing researchers to focus on innovation.
• Enabling Autonomous Research: DKG lays the groundwork for AI agents capable of autonomous research, accelerating the research cycle and potentially leading to breakthroughs.
• Returning to the Semantic Web Vision: DKG realizes Tim Berners-Lee's original vision of a Semantic Web, where machines can understand and interpret data like humans.

Staking and Rewards

To align economic incentives with the decentralized, multi-agent research pipeline, we introduce a comprehensive reward system that directly links scientific contributions with token-based returns. This model underpins the BioAgent deployment and ensures that every layer, from data curation to hypothesis generation, remains robustly incentivized.

Figure 3: BioDAO Reward and Staking Process

The key elements are as follows:

1. Reward Agent & Onboarding Trial

• Reward Agent: A dedicated module continuously measures and tracks user contributions across the BioDAO ecosystem.
• Trial Period: In the initial 1–2 weeks following deployment, users benefit from a blanket reward (e.g., 40% APY) for any agent that contributes to the framework—be it gathering papers, curating the knowledge graph, or generating hypotheses. This trial phase incentivizes broad participation and rapid onboarding.

2. Performance-Based Rewards

• Post-Trial Incentives: Once the trial period concludes, rewards shift to performance-based distributions. This approach is designed to ensure that continued rewards are contingent upon demonstrable value addition:

• Knowledge Expansion: Stage 1 (month 1) - Agents that verifiably enrich the biograph (e.g., by adding new scientific papers or data assets) earn rewards between 100–200% APY.
• Hypothesis Generation:

• Open Source Hypotheses: Stage 2 (Month 2) - Hypotheses released under an open source license (and thereby owned by the DAO) generate standard rewards (200–300% APY).
• Closed Source Hypotheses: If users opt to retain proprietary control over their hypotheses—but subsequently hand them over for DAO evaluation—the rewards can be significantly higher (1000–2000% APY) when such proposals secure funding.

3. Staking Mechanism & Compounding

• Staking Requirements: To deploy any BioAgent within the framework, users must stake both BIO and the DAO’s native token, VITA. This deposit forms the basis for accruing APY.
• Compounding Returns: With APY applied to the staked deposit, contributions that continue to add value can see their rewards compound over time.
• Collaboration and Token Sink: The model encourages not only individual commitment but also collaborative pooling of resources. Scientists may lend or combine tokens to optimize their staking deposits, thereby reinforcing a token sink and fostering long-term commitment to the ecosystem.

Our incentive model begins with a 1–2 week trial period offering a fixed beginner APY to all participants, transitioning into performance-based rewards that align directly with the quality and impact of contributions.

Agents that expand the biograph earn 100–200% APY, while those generating hypotheses receive 200–300% APY if open-sourced, and up to 1000–2000% APY if a closed source hypothesis is selected for funding. This model requires users to stake BIO and OLAS (and later the BioDAO’s token) , with rewards compounding over time and further enhanced through collaborative deposit dynamics, ultimately driving exponential returns when high-impact intellectual property is generated.

Impactful Contributions

To fully realize the potential of decentralized autonomous scientific research research, BIO leverages strategic collaborations to empower BioDAO members to contribute effectively across various domains. These collaborations are essential for enhancing the AI-driven research ecosystem and ensuring that scientific discoveries are accelerated. By integrating with key platforms and protocols, BIO enables its community to engage in critical activities such as:

• Streamlining workflows: Making it easier for new members to find and contribute their skills.
• Generating targeted research proposals: Facilitating the creation of fundable and impactful projects.
• Building autonomous applications: Providing the infrastructure for continuous and independent research processes.
• Training therapeutically focused AI models: Equipping BioDAOs with the tools for precision insights and discoveries.

These collaborations will ensure that BIO remains at the forefront of decentralized scientific innovation, maximizing the impact of its community members

OLAS

A solution to coordinating autonomous multi-agent systems within the BIO.ai ecosystem, it uses staking mechanisms to incentivize the running of BioAgents by DeSci community members and supports co-ownership and networking of various agent frameworks.  Its integration with other AI Agent stacks like ELIZA enables a heterogenous network of agents to perform knowledge accumulation, hypothesis testing and experiment planning, contributing to BIO.ai’s goal of accelerating innovation.

BeeARD

Creating multi-agent systems to perform various functions that ultimately lead to the generation of IP-NFTs. Its primary objective is to create targeted, fundable hypotheses by integrating BioDAOs, AI agents, and decentralized knowledge graphs. Secondarily it will support BIO’s goal of creating an AI-ready knowledge base - through literature reviews - by ensuring that research data is verifiable and structured for seamless processing. 

Coordination Network

The Coordination Network streamlines BioDAO workflows by allowing individuals to massively scale (and be awarded for) their capabilities. By connecting skills and expertise together in pipelines and allowing them to be shared across DAOs, it simplifies onboarding and directs contributors to optimal actions. Integration with BIO creates pathways for augmented representation and effective participation in decentralized mechanisms, aligning with the vision of frictionless knowledge sharing and real-time collaboration.

Prime Intellect

Prime Intellect's decentralized compute capabilities are key to training specialized LLMs on BioDAO datasets, yielding precise insights for areas like neurodegeneration and longevity. These models will be community-governed, scalable, and interoperable. This empowers BioDAOs to build domain-specific knowledge and therapeutic LLMs, transforming BIO.ai into a substrate for scientific discovery. Prime Intellect can also be leveraged for inference allowing AI agents to run complex tasks without straining local resources.

Synergies

Ensuring that contributions are not only plentiful but also meaningful requires a focus on aligning the aforementioned incentives with verifiable quality and real-world impact. This involves transitioning from simple participation rewards to performance-based metrics that prioritize valuable additions to the knowledge graph and the generation of fundable hypotheses

• Addresses Scaling Challenges: The roadmap details how the multi-agent system overcomes limitations in the current BioDAO model.
• Utilizing a DKG: The roadmap explains the use of multi-agent systems to gather and curate knowledge into a robust, decentralized knowledge graph.
• AI-Driven Hypothesis Generation: It describes how specialized agents propose and refine novel hypotheses using the decentralized knowledge graph.
• Streamlined R&D: It highlights the conversion of promising ideas into actionable R&D plans, streamlining laboratory workflows and automating legal agreements.
• IP Protection and Monetization: It explains the safeguarding and monetization of discoveries through advanced licensing frameworks or IP-NFTs using the Molecule Protocol

The Complete Picture - KITBASH

This roadmap outlines a comprehensive, AI-driven research pipeline, transforming BioDAOs into collaborative hubs of scientific innovation. KITBASH, an online dashboard, serves as the central nervous system for this ecosystem, visually demonstrating real-time hypothesis generation and providing a unified interface for all stakeholders. It addresses the challenges of fragmented scientific workflows by integrating diverse components, from initial data gathering to IP-NFT creation.

Figure 6: KITBASH - modified from FutureHouse Schematic - a unified User Interface to Demonstrate Process and Flow.

The core elements of this complete picture are:

• World Model: KITBASH aggregates and integrates all available data and knowledge into the SKG (The World Model), providing a comprehensive and easily accessible overview of the current state of research. This foundational layer is built and maintained through the efforts of Contributor Agents, ensuring a robust and reliable knowledge base.
• Hypothesis Generation: Leveraging insights from the World Model, KITBASH facilitates the generation of new, testable research questions. Consumer Agents utilize this data to formulate innovative hypotheses, bridging the gap between raw data and actionable research directions. The real-time visualization within KITBASH allows users to observe this dynamic process, fostering engagement and transparency.
• Experimentation: KITBASH encompasses the design, contractual, and laboratory workflow required to test the generated hypotheses. Designer and Contract Agents streamline the experimental process, ensuring efficient and legally sound execution of research plans.
• IP-NFT: The culmination of a successful discovery is the creation of an IP-NFT, representing the intellectual property in a tokenized format. IP Agents oversee the lifecycle of these IP-NFTs, managing patent filings and data provenance.

Key Points:

• Full-Stack Solution: This interconnected system of agents and processes creates a full-stack solution for decentralized, AI-driven research, addressing the entire research lifecycle.
• An Online Dashboard (KITBASH): To visually demonstrate that hypothesis generation is occurring in real time and on an ongoing basis.
• Collaborative, Incentivized, and Verifiably Open Science: Each agent builds on the outputs of the last, ensuring transparency, interoperability, and community governance at every step, which is the essence of the DeSci vision.

KITBASH unifies these components, promoting collaboration, incentivization, and verifiable open science. By visualizing the data, the hypotheses, and experimental designs in one place it allows community members, DAO members, autonomous agents to seamlessly interact with each other.

Benefits:

• Transparency: Every milestone—data, hypothesis, experiment, IP—remains transparent and auditable.
• Interoperability: Data and processes are interoperable, allowing for seamless integration and collaboration.
• Community Governance: The decentralized nature of the system allows for community governance and ensures that the research is open and accessible to all.

This approach to a complete picture addresses fragmented scientific workflows, and enables transparent milestones, and ultimately accelerates the process of scientific discovery. Overall, this roadmap presents a comprehensive solution for decentralized, AI-driven research that is transparent, collaborative, and open to all.

Breakdown of the Agents

1. Contributor Agents

These form the starting gate for the entire multi-agent pipeline by collecting, verifying, and structuring the data that fuels every subsequent stage.

They are designed as standalone modules that can be developed, tested, and refined independently, ensuring a robust foundation of high-fidelity knowledge assets before the more complex Consumer, Designer, Contract, and IP Agents come online.

Initially this will be composed of two agents, each performing a specific sub task; (1) Literature review and (2) Knowledge Graph creation. This modular approach allows for incremental upgrades, stronger quality control, and smoother integration as the rest of the system evolves around a well-validated dataset.

a) Literature Review Agent

Please read for a fuller description of the agent:

Agent 1a: BeeARD “Swarm” (Repository Builder)

Role: Aggregates and distills the latest scientific literature and existing datasets relevant to the future generation of a hypothesis.

Implementation Detail

• Powered by“BeeARD Swarm,” which can crowdsource or automate the retrieval and summarization of papers.
• Uses a foundation model (LLM) for text understanding and structured extraction of insights.
• Outputs are deposited into a Knowledge Repository (KR).
• TBD if this KR will be centrally stored or using a decentralised network. If the latter, then these agents will require subsidisation with AR (or other decentralised storage network tokens)

Task Focus

• A multi‐agent swarm that queries PubMed, Google Scholar, etc. to gather domain‐specific papers (e.g., longevity, aging mechanisms, etc.).
• Each sub‐agent may specialize in a different query strategy or subfield (e.g., “mitochondrial function,” “immunosenescence,” etc.).
• Collated outputs form a shared knowledge repository—a local database or file store holding parsed text, partial “triplets,” and metadata.

Core Inputs/Outputs

• Input: Scientific APIs and web search results, PDF papers, DOIs.
• Output: “Raw” structured data or highlight sets, stored in the repository with associated confidence scores or tags.

Performance Metric

• Volume of unique, validated references and data chunks aggregated.
• Low duplication rate, high completeness of coverage.

b) Graph Creation Agent

Please read for a fuller description of the agent:

Agent 1b: Graph Creation Agent (Eliza DKG Plugin)

Role: Curates verified information and transforms it into structured knowledge‐graph assets on a Knowledge Graph (KG).

Implementation Detail

• A human‐in‐the‐loop (TBD) could provide oversight to ensure data quality, correct relationships, and context - this wont be part of the OLAS pearl implementation, but likely at a DAO level to decide the “types” of knowledge to extract from the repository for adding to the graph.
• Use a “Eliza” plugin to unify biological concepts, entity relationships, and metadata and insert them into the KG.
• TBD if this KG will be centrally stored or using a decentralised network. If the latter, a DKG, then these agents will require subsidisation with TRAC (if using OriginaTrail).
• Result: A living knowledge graph that becomes the backbone of subsequent discovery work.

Task Focus

• Consumes the BeeARD repository, filters for high‐confidence or user‐approved items, and writes them to the decentralized knowledge graph (e.g., via OriginTrail or possibly Neo4j for quick/dirty PoC).
• Enforces final curation logic: which data is minted on‐chain, which is flagged for further review.

Core Inputs/Outputs

• Input: The “repository data” from BeeARD—i.e., validated text, partial triplets, or metadata.
• Output: On‐chain or decentralized graph entries, minted as knowledge assets (NFTs) or hashed proofs.

Performance Metric

• Number of successful, non‐duplicative DKG submissions, measuring accuracy and reliability (low error rate).
• Possibly a “confidence threshold” success measure (e.g., X% of minted entries pass subsequent checks with no corrections).

Testing & Coordination

Final Summary

• BeeARD (Multi‐Agent Swarm): Gathers & consolidates raw scientific knowledge into a local “repository.” Achieves scale by coordinating specialized search & domain sub‐agents.
• Graph Creation Agent (Eliza + DKG Plugin): Consumes BeeARD’s output, finalizes the data, and writes on‐chain.
• Both Agents = Separate Binaries for OLAS Pearl. Operators can choose which agent to run, earn OLAS/BIO, and collectively power the end‐to‐end scientific pipeline.
• Choosing Which Data to Mint

• Rely on confidence scoring plus optional human in the loop.
• Use duplication checks to avoid spamming or repeated entries.

• Incentives

• BeeARD swarm operators get paid for collecting and structuring raw data.
• DKG agent operators get paid for minting high‐quality knowledge assets on‐chain.

Following this roadmap lets you quickly prototype a swarm-based data ingestion + curated on‐chain knowledge flow, all under OLAS Pearl’s operator‐staking model.

2. Consumer Agent

Leveraging a decentralized, AI-driven infrastructure that unifies symbolic and neural methods for real-time discovery. By integrating the DKG with therapeutically focused, fine-tuned LLMs, these agents will continuously ingest structured biomedical data, rigorously verify its provenance on-chain, and leverage language models to surface novel insights—while minimizing “hallucinations.”

This neural–symbolic synergy is especially critical in biomedical research, where each AI-generated hypothesis must stand up to both human and on-chain scrutiny. Each proposal (hypothesis) becomes an auditable asset—referencing the evidence behind it, amenable to community validation, and ready for DAO-based funding or licensing via “Hypothesis NFTs.” 

In short, the consumer agent transforms domain-specific knowledge into a frictionless engine of innovation, ensuring breakthroughs remain transparent, interoperable, and collectively owned.

Once Contributor Agents have collected and curated a robust knowledge base—minting verified data on the Decentralized Knowledge Graph (DKG)—the next step is to transform this raw insight into actionable hypotheses. The Consumer Agents fill this role by autonomously generating concise, evidence-backed proposals, leveraging both machine-driven logic and, where needed, human expertise via skill libraries.

Please read for a fuller description of the agent:

Agent 2: Consumer Agent (Hypothesis Generator)

Role:

• Primary Objective: Distill structured data (e.g., triplets in the DKG) into new ideas—drug targets, gene-pathway synergies, or mechanistic hypotheses.
• Skill Libraries for Pipeline Automation: Taps into a growing repository of expert “skills” (e.g., proposal review, scoring frameworks) contributed by the broader community. These skills can be invoked automatically by the agent or enhanced by human specialists.
• On-Chain Publishing: Converts validated hypotheses into “Hypothesis NFTs,” letting DAO members fund, vote on, or predict the potential success of each proposal.

Human-in-the-Loop vs. Fully Automated

• Standalone Autonomy

• In typical “one-click” mode, the Consumer Agent autonomously queries the DKG, crafts new hypotheses, and mints them on-chain—no human step required.
• Ideal for citizen scientists who simply want a “Generate Hypothesis” button in Pearl.

• Optional Expert Oversight

• For high-value or complex projects, the Consumer Agent can route outputs to domain experts (or a “hive mind” of specialists) for final sign-off or additional refinement.
• This ensures cognitive liberty and quality control, allowing humans to “fork” or upgrade pipelines with improved logic if needed.

Implementation Detail

1. DKG & Skill Library Integration

• DKG Queries: The agent systematically scans newly minted knowledge assets for underexplored relationships—e.g., a compound that might impact a disease pathway.
• Skill Libraries: Borrowing from frameworks like coordination.network, the Consumer Agent can load prebuilt pipelines (e.g., “evaluate early-stage research,” “freedom-to-operate check,” “TRL scoring”).

• Contributors to these skill libraries can earn fractional rewards whenever their skill is invoked and leads to a valuable outcome.

2. Symbolic + Neural Synergy

• Symbolic Reasoner: Identifies promising node-link patterns or “gaps” in the DKG.
• Fine-Tuned LLM: A therapeutically focused model (trained on domain-specific corpora) converts symbolic candidates into a coherent, single-sentence proposal—automatically referencing relevant data.

3. Audit Trails & Transparency

• Each hypothesis generation flow produces a step-by-step record (audit trail), showing how the agent arrived at its conclusion.
• Human experts can review, improve, or fork these workflows—continuously refining the “best practices” embedded in the system.

Task Focus

1. Hypothesis Generation

• Pull structured data (triplets) from the DKG, identify high-potential connections, and form them into testable research proposals.

2. Quality Evaluation

• (Optional) Run each proposal through additional skill pipelines (e.g., an “R&D readiness” or “grant review” module) before on-chain minting.

3. Token & DAO Integration

• Stake tokens (OLAS + Impact Token) to operate the agent; minted hypotheses appear on-chain for bonding curves or prediction markets—enabling fractional investment in new ideas.

Core Inputs & Outputs

• Inputs:

• DKG Entries: Verified triplets curated by Contributor Agents.
• Skill Modules: An expanding library of “how-to” pipelines, from basic scoring to advanced IP analysis.
• Fine-Tuned Biomedical LLM: For clarity, creativity, and domain expertise in final proposals.

• Outputs:

• Automated Hypotheses: One-sentence interventions or mechanistic connections referencing supporting DKG data.
• Evaluation Trails: A stored history of which skill modules ran and how each step contributed to final scoring.
• Hypothesis NFTs: Minted on-chain proposals for DAO voting, market bets, or funding.

Performance Metrics

1. Adoption Rate

• Percentage of newly generated hypotheses that secure DAO funding or spark collaborative R&D.

2. Expert Endorsement

• Volume of proposals that pass human or multi-expert validation steps—an indicator of real scientific value.

3. Skill Usage & Contribution

• Frequency with which each pipeline (in the skill library) is invoked, fostering a feedback loop where popular or high-performing skills gain traction.

Overall Flow in Pearl

1. User Onboarding

• Operators choose the Consumer Agent container, stake OLAS + Impact Token, and optionally pick specialized “skill modules” to enhance output.

2. Data Retrieval & Hypothesis Drafting

• The agent queries the DKG, harnesses the symbolic reasoner, and uses the therapeutically focused LLM to formulate concise proposals.

3. Skill Pipeline

• Automated checks (e.g., TRL scoring, cost–benefit analyses). For advanced reviews, the agent may route outputs to human experts or an off-chain “hive mind.”

4. On-Chain Minting

• The top-ranked proposals become “Hypothesis NFTs,” published in the DAO environment. DAO members then invest, vote, or speculate on the proposition.

5. Reward Distribution

• If a hypothesis matures into an IP-bearing discovery, the agent operator and skill-contributors claim fractional rewards.

Fine-Tuned LLMs (Prime Intellect)

Please read for a fuller description of the LLM:

Prime Intellect Fine-Tuned LLMs

Central to the Consumer Agent’s success is a therapeutically focused language model designed to parse domain-specific data with minimal hallucination. By integrating with a Prime Intellect-powered HPC layer:

1. Precision Over Generic Outputs

• A domain-specialized LLM, trained or fine-tuned on curated biomedical datasets, can detect subtle but critical relationships (e.g., candidate biomarkers, gene-drug interactions) that a general-purpose model might overlook.

2. Reduced Noise & Hallucination

• By honing in on specific therapeutic areas, the model’s output remains grounded in verified knowledge, lowering the risk of “wild” hypotheses that derail R&D.

3. Skill-Driven Queries

• Each skill pipeline can tap the LLM’s advanced reasoning to produce thorough, justified conclusions—e.g., how likely a particular compound is to mitigate a specific disease pathway.

4. Transparency & Iteration

• All generated hypotheses, prompts, and final recommendations are stored in an audit-friendly format—allowing the broader BioDAO or BioGraph community to trace the logic, refine methods, and share improved “skill libraries.”

5. Evolving Model & Ecosystem

• As new data enters the DKG or skill libraries expand, the LLM can undergo periodic re-training or fine-tuning runs. Over time, the synergy of neural and symbolic methods grows more powerful and reliable for advanced biomedical breakthroughs.

Final Summary

By wedding the DKG’s structured clarity with a human-verified skill library and Prime Intellect–hosted biomedical LLM, Consumer Agents become the linchpin for scalable, auditable hypothesis generation. This architecture not only removes friction for individual scientists—citizen or professional—but also fosters a robust, token-incentivized ecosystem where each new skill, dataset, or validated hypothesis expands the collective intelligence of the BioGraph network.

3. Designer Agent

• Role: Translates approved hypotheses into actual experimental designs (in‐silico, in‐vitro, in‐vivo).
• Implementation Detail:

1. Takes the minted hypothesis (or IP‐NFT minted from the hypothesis) and sets up experiments.
2. Coordinates with foundation models that can help design protocols, choose appropriate assays, or predict best candidate molecules.

• Output:

1. A set of experiment design documents (in‐silico, in‐vitro, in‐vivo).
2. An “IP‐NFT” token that encapsulates the new or improved intellectual property around the design.

4. Contract Agent

• Role: Operationalizes experiments by handling the logistics, contracts, and manufacturing aspects needed to run the designed studies.
• Implementation Detail:

• Uses the IP‐NFT as the reference for the intellectual property to be tested.
• Draws up contract research agreements and sends out requests for quotes to CROs (Contract Research Organizations).
• Handles the supply chain (coordinate with CMO/compound libraries for chemical supply).

• Outcome:

• A fully executed R&D plan—complete with contracts, supply lines, and assigned service providers—ready for real‐world lab experiments.

5. IP Agent

• Role: Oversees the IP‐NFT life cycle, manages patent filings, freedom‐to‐operate (FTO) searches, and data provenance.
• Implementation Detail:

• Gathers experimental data from CROs; updates the IP‐NFT with new datasets.
• Automates or semi‐automates FTO analysis, ensuring that newly generated data or inventions do not infringe existing patents.
• Manages patent filing if the results show novelty and commercial potential.

• Outcome:

• Intellectual property is continuously updated, protected, and leveraged for potential commercialization or further research.

Key Themes & Questions

1. One Knowledge Graph vs. Many

• Some participants propose a single, unified Knowledge Graph to store objective “triplets” (e.g., gene X encodes protein Y). Others entertain a “multi-graph universe,” in which separate swarms of agents generate many different graphs.
• Core Question: Does a single robust, curated DKG (Decentralized Knowledge Graph) suffice for longevity data, or do we want to enable many parallel KGs with their own token mechanics?

2. Tokenization & Incentives

• How do we introduce a speculative element (e.g., bonding curves, prediction markets, IP‐NFTs) so that retail or DAOs invest in hypotheses?
• Where do these tokens and bond curves live (existing protocols, fresh contracts, or a “Pump Science” fork)?

3. Hypothesis Generation

• A major near-term priority is to show real value from AI‐driven “literature + data review” and subsequent hypothesis creation.
• How do we bootstrap fast? Some want a minimal MVP that simply generates large volumes of hypotheses—even if many are low-quality—then let markets filter them.

4. DAO Integration

• Several references to plugging the agent system into a specific DAO (e.g., VitaDAO) as a first test bed for real governance, IP licensing, or lab experimentation.
• Core Question: Should we pick one DAO (e.g., VitaDAO) for a deeper pilot or aim for a more general “Bio Agents” framework that any longevity DAO can adopt?

5. Storage & Infrastructure

• Mention of using existing DKG solutions (e.g., OriginTrail, Neo4j, etc.) in parallel with IPFS, Arweave, or more centralized buckets at first.
• Need to define a lightweight, hacky approach vs. fully decentralized approach for storing knowledge and agent outputs.

6. Decentralized Compute (Prime Intellect)

• The final transcript highlights using “Prime Intellect” (or a similar HPC network) to run bigger AI/ML tasks (e.g., advanced model training, in‐silico biology).
• Key Point: Eventually we want large-scale autonomous research—e.g., an AI agent that can run big computations, then propose and refine real experiments.

Action Requirements & “Who Owns What?”

Below is a high-level breakdown of tasks derived from the transcripts, along with suggested ownership.

A. Solidify the Knowledge-Graph Foundation

1. Define the DKG MVP

• Owner: A small “core infra” team (possibly from the Coordination Network + any DKG partner like OriginTrail)
• Actions:

• Decide on single DKG approach vs. multiple parallel knowledge repositories.
• Implement a basic schema for “longevity” domain (genes, proteins, interventions, known relationships).

2. Literature-Review Agent & Data Ingestion

• Owner: Collaboration among BioGraph devs, plus external AI integrators (e.g., BeeARD, “paper-QA,” or any LLM plugin team).
• Actions:

• Connect to open-access papers or private longevity datasets (via a “secret” or licensed library).
• Clean, parse, and embed key facts or “triplets” into the DKG.

B. Hypothesis Generation & Token Mechanics

3. Consumer (Hypothesis) Agent

• Owner: A small “Hypothesis” dev team (Coordination Network, or relevant DAO devs).
• Actions:

• Create a minimal agent that reads from the longevity knowledge base and proposes new, testable ideas.
• (Optional) Integrate with a bonding curve or “Pump Science”–style platform so that each new hypothesis can be minted or crowdfunded.

4. Speculative / Funding Layer

• Owner: Token-engineering or DeFi-savvy members within the group (someone with experience in bonding curves, e.g., “Pump.Fun,” or other open‐source frameworks).
• Actions:

• Decide whether to fork an existing bonding-curve system (e.g., “Pump.Fun for science”).
• Simplify the flow so the “hypothesis tokens” can be minted with minimal contract overhead.

C. Next-Level Agents (Designer, Contract, IP)

5. Designer Agent

• Owner: A specialized R&D dev sub-team (possibly folks with bench science experience).
• Actions:

• Start with an “in-silico” experiment design module (lowest friction)
• Later, expand to in-vitro or in-vivo, requiring connections to actual labs or CROs.

6. Contract Agent

• Owner: Legal & business dev contributors (the “CRO collaboration” cluster).
• Actions:

• Automate drafting of NDAs, research agreements, manufacturing contracts.
• Possibly integrate with existing “IP-NFT” frameworks for on-chain licensing.

7. IP Agent

• Owner: IP-legal specialists plus smart-contract devs.
• Actions:

• Ensure any newly validated data or discoveries get minted into an IP-NFT.
• Provide freedom-to-operate searches and patent filings if the agent detects novel, patentable results.

D. Decentralized Compute Integration

8. Prime Intellect / HPC for Agents

• Owner: HPC or “Prime Intellect” team + the BioGraph dev core.
• Actions:

• Set up a test environment for large-scale fine-tuning or advanced ML tasks (e.g., “longevity model training”).
• Provide an easy on-ramp so that new agents can “rent” HPC cycles when heavier computations are needed.

E. Community-Building & Governance

9. DAO Pilots (e.g., VitaDAO)

• Owner: VitaDAO leads or other pilot DAOs.
• Actions:

• Embed the new “Consumer/Hypothesis” Agent into their Discord and/or governance platform.
• Pilot small on-chain votes to fund or “mint” interesting hypotheses.
• Use the Social/Operator Agent to publicize results, gather feedback, and unify the broader longevity community.

10. Hackathons & Bounties

• Owner: All collaborating orgs—BioGraph core, DAOs, HPC providers, etc.
• Actions:

• Publish a set of “Request for Agents” or “bounty boards” listing specific tasks (e.g., “build a knowledge-graph plugin,” “design an auto-curator,” “write a contract agent for CRO deals”).
• Offer Bio or DAO tokens (or stablecoins) as bounty rewards.
• Run a developer hackathon to onboard new contributors and refine agent frameworks.

Recommended Next Steps

1. Finalize MVP Roadmap & Publicize

• Draft a public doc/blog post explaining the end-to-end vision of “Bio Agents” in longevity.
• Show how each agent (from Lit Review to IP) forms a chain of value.
• Outline the near-term MVP: Contributor Agents → Basic Hypothesis Agent → (Optional) Funding or Tokenization Flow.

2. Stand Up a “Longevity DKG”

• Pick a workable DKG stack (OriginTrail, Neo4j + AR, IPFS, etc.).
• Ingest a curated but modest dataset of longevity papers (plus expansions over time).
• Provide a minimal front-end or API so community devs can see the knowledge structure.

3. Launch the Hypothesis Agent (Beta)

• Give it read-access to the DKG.
• Let it produce testable relationships or “ideas.”
• Pipe the results into Discord/X for feedback.
• (Optional) Experiment with a small “hypothesis bonding curve” to gauge interest.

4. Set Up the HPC On-Ramp

• Allow agents to request HPC from “Prime Intellect” (or a similar HPC pool).
• This fosters advanced tasks like model fine-tuning or more computationally intense experiment designs.

5. Run a Public Hackathon

• Publish a “Request for Agents” (RFA) or agent add-ons:

• E.g. “Social Media Agent,” “DKG Curation Agent,” “Design Agent for in-silico protocols,” etc.

• Offer token bounties from BioGraph or pilot DAOs.
• Onboard open-source devs and see which agent modules gain traction.

6. Iterate & Expand

• As soon as the Contributor & Consumer Agents show robust usage, move on to designing the Designer, Contract, and IP Agents.
• In parallel, refine the token-economics and unify the user experience so novices can easily “spin up” new agents or participate in hypothesis markets.

Conclusion

It’s clear there is a lot of complexity(!) around building a truly agent-driven, decentralized R&D pipeline—especially for longevity. Key to success is breaking the problem into digestible phases:

1. Establish the knowledge foundation (a longevity DKG + simple contributor agents).
2. Unleash a hypothesis generator that taps that knowledge base and proposes new ideas.
3. Tokenize and fund the best ideas (bonding curves, IP‐NFTs, or other DeFi primitives).
4. Automate R&D (design, contracting, IP) in later phases.
5. Leverage HPC to run advanced tasks at scale.

By running small pilots (e.g., with VitaDAO) and hosting hackathons for more specialized agents, the community can gradually assemble the full pipeline. This approach ensures real‐world impact, early wins, and the momentum to build out the entire quest + hypothesis‐generation vision.